3Neil A,Muchatuta,Michael Paech.Management of postoperative nausea and vomiting focus on palonosetron[J].Therapeutics and Clinical Risk Management,2009,5:21-34.
4GRALLA R,LICHINITSER M,VAN DER VEGT S,et al.Palonasetron improves prevention of chemotherapy-induced nausea and vomiting following moderately emetogenic chemotherapy:results of a double-blind randomized phase Ⅲ trail comparing single dosed of palonosetron with ondansetron [ J ].Ann Oncol,2003,14 (10):1570-1577.
5STOLTZ R,CYONG JC,SHAH A,et al.Pharmacokinetic and safety evaluation of palonosetron,a 5-hydroxytryptamine-3 receptor antagonist,in U.S.and Japanese healthy subjects [ J].J Clin Pharm,2004,44 (5):520-531.
6STOLTZ R,PARISI S,SHAH A,et al.Pharmacokinetics,metabolism and excretion of intravenous [ 14C ]-palonosetron in healthy human volunteers [ J].Biopharm Drug Dispos,2004,25(8):329-337.
7NAVARI RM.Pathogenesis-based treatment of chemotherapy-induced nausea and vomiting-two new agents[ J].J Support Oncol,2003,1 (2):89-103.
8EISENBERG P,FIGUEROA-VADILLO J,ZAMORA R,et al.Improved prevention of moderately emetogenic chemotherapy-induced nausea and vomiting with palonosetron,a pharmacologically novel 5-HT3 receptor antagonist:results of a phase Ⅲ,single-dose trial versus dolasetron [ J ].Cancer,2003,98 (11):2473-2482.
